PUNE, India, July 29, 2016 /PRNewswire/ —
According to a new market research report “Urinalysis Market by Product Type (Dipstick, Reagent, Analyzers, POC), Test Type (Biochemical, Sediment, Microscopic, Flow-Cytometric), Application (Diabetes, UTI, Kidney, Liver Disease, Pregnancy), End User (Hospitals, Diagnostic Labs) – Forecast to 2021” published by MarketsandMarkets, The global market is expected to reach USD 1.91 Billion by 2021 from USD 1.32 Billion in 2016 at a CAGR of 7.6% from 2016 to 2021.
Browse 278 market data Tables and 41 Figures spread through 223 Pages and in-depth TOC on “Urinalysis Market“
Early buyers will receive 10% customization on this report.
Report provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the Urinalysis Market along with the estimates and forecasts of the revenue and market share analysis. The major factors driving the growth of this market are raising prevalence of kidney diseases and urinary tract infections, implementation of PPACA, technological advancements, increasing adoption rate of point-of-care urinalysis devices, increasing healthcare expenditure and increasing geriatric population.
The reporting segments in this market include product type, test type, applications, and end user. On the basis of product type, the Urinalysis Market is segmented into consumables and instruments. Consumables are expected to account for the largest share of the market due to factors such as wide use of disposables in urinalysis testing and research, the introduction of new and advanced reagents & dipsticks and the utilization of disposables at a larger scale in the market.
On the basis of test type, the Urinalysis Market is segmented into biochemical urinalysis and sediment urinalysis. The biochemical urinalysis segment is expected to account for the largest share of the global Urinalysis Market in 2016. The rapidly growing geriatric population and rising prevalence of kidney diseases and urinary tract infections are the key factors propelling the growth of this market.
On the basis of end user, the Urinalysis Market includes hospitals and clinical laboratories, diagnostics laboratory, research laboratories and institutes and home care settings. The hospitals and clinical laboratories segment is expected to account for the largest share of the global Urinalysis Market in 2016. Extensive use of dipsticks by hospitals and clinical laboratories is the major factors driving the growth of this market.
Based on applications, the global Urinalysis Market is segmented into disease diagnostics and pregnancy tests. Disease diagnostics segment is expected to account for the largest share of the market during the forecast period. Growth in this segment is driven by the factors such as advancement in the development of new urinalysis tests for better and early diagnosis of chronic diseases.
Based on geography, the global Urinalysis Market is segmented into North America, Europe, Asia and Row. Asia segment is expected to grow at the highest CAGR during the forecast period. Growth in this segment is driven by the factors such as rising demand for urine testing products, increasing healthcare expenditure, rising prevalence of diabetes, and growing geriatric population are driving the growth of the Urinalysis Market in this region.
Speak to our research experts:
The key players in the Urinalysis Market include Beckman Coulter (U.S.), Roche Diagnostics (Switzerland), Siemens AG (Germany), Sysmex Corporation (Japan) and ARKRAY, Inc. (Japan).
Browse Related Reports:
In Vitro Diagnostics (IVD) Market by Product (instruments, Reagents, Software, Service) Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Hematology) by Application (Diabetes, Cancer, Cardiology, Autoimmune Diseases) – Forecast to 2020
Point-of-Care Diagnostics Market by Products (Glucose, Cardiometabolic Monitoring, & Infectious Disease Testing Kits, Cardiac & Tumor Markers), End Users (Home, Hospitals, Ambulatory Care), Over-the- Counter & Prescription Based – Global Forecast to 2021
Know More About our Knowledge Store @ http://www.marketsandmarkets.com/Knowledgestore.asp
MarketsandMarkets is the largest market research firm worldwide in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors.
M&M’s flagship competitive intelligence and market research platform, “RT” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Markets and Markets
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/medical-devices
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets